Sign in

NCT06733181Completed

The REMINDER Program for Older Adults Supported by Residential and Daycare Facilities

The REMINDER, a Multidomain Dementia Risk Reduction Program for Older Adults Supported by Residential Care Facilities: a Feasibility Study

Source: ClinicalTrials.gov · Last updated 23 Apr 2025

Brief summary (registry, in English)

Dementia and mild cognitive impairment (MCI) deeply impact individuals' well-being and are expected to increase due to population aging, with global cases projected to rise to 152.8 million by 2050. Social isolation, accounting for 4% of dementia cases, emerges as a critical modifiable risk factor, particularly in institutionalized older adults, where it significantly raises dementia risk. To address these challenges, the REMINDER program was developed as a tailored, multidomain intervention to reduce dementia risk, emphasizing social and cognitive engagement and advancing its adaptation and evaluation in Residential and Daycare Facilities (RDF). To assess the feasibility of REMINDER in older adults supported by RDF (recruitment, adherence, retention, acceptability, accessibility, and usability) and explore potential changes in cognitive and psychosocial outcomes.

Status (registry)
Completed
Study type
Interventional
Enrollment
25 (actual)
First submitted
29 Nov 2024
Start date
20 Jul 2023
Primary completion date
31 Jul 2024
Lead sponsor
University of Coimbra
NCT number
NCT06733181

What you commit to

  • Study type: Interventional
  • Participants enrolled: 25
  • From 20 Jul 2023 to the primary completion date, 31 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have a clinical diagnosis of dementia and/or MMSE scores below the cutoff for the presence of dementia (MMSE \< 22-27, depending on education level)
  • Have a psychiatric or neurological condition that impairs cognition in the long term

Other

  • Have sensory and functional deficits that compromised their participation in the neuropsychological assessment and throughout the intervention sessions.

Who the study is looking for

  • Individuals aged 65 years and older
  • RDF users
  • Those with elementary reading and writing skills.

Age in the registry: 65 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Faculty of Psychology and Education Sciences
Coordinator of this site? Confirm its status
CoimbraPortugalUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.